Patel Chem Specialities Ltd
Patel Chem Specialities H1 FY27 Revenue up 25.07% YoY, Capacity Expanded
RESULTS
▲ Positive Development
MEDIUM RISK
📅 Filed on BSE: 06 Nov 2026, 01:30 PM IST · BSE ID: 30abf6bb-9e80-4bbd-86b3-4c22121b59f7
View Original BSE Filing (PDF)
💡
In Simple Terms
The chemical company grew its half-year sales by 25.07% and significantly increased its manufacturing capacity.
🤖 AI Summary
- Patel Chem Specialities reported H1 FY27 revenue from operations at ₹7,649.10 Lakhs, a 25.07% YoY increase.
- EBITDA for H1 FY27 increased by 14.13% YoY to ₹1,013.52 Lakhs; PAT grew by 2.28% to ₹626.90 Lakhs.
- Company completed Talod facility expansion, increasing annual production capacity from 720 MT to 4,500 MT.
- Shareholders' funds strengthened to ₹105.77 crore as of September 30, 2026, up 6.30% from March 31, 2026.
- Capital work-in-progress increased by 50.66% to ₹21.86 crore as of September 30, 2026.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Revenue from Operations (H1 FY27)
7,649.10 Lakhs
25.07%
EBITDA (H1 FY27)
1,013.52 Lakhs
14.13%
PAT (H1 FY27)
626.90 Lakhs
2.28%
Shareholders' Funds (as of Sep 30, 2026)
105.77 crore
Annual Production Capacity (post-expansion)
4,500 MT
Total Borrowings (as of Sep 30, 2026)
23.74 crore
🏢 How This Affects the Company
The capacity expansion from 720 MT to 4,500 MT positions Patel Chem Specialities to meet growing market demand and improve delivery schedules, potentially enhancing market share in pharmaceutical excipients and speciality chemicals.
Shareholders' funds increased by 6.30% to ₹105.77 crore. Total borrowings increased to ₹23.74 crore, up from ₹15.23 crore at FY26 end, reflecting funding for capital expenditure.
The completed expansion at the Talod facility substantially increases annual production capacity, with trial batches commenced and commercial production expected shortly.
EBITDA and PAT margins moderated by 127 bps and 183 bps respectively, indicating potential pressure on profitability despite revenue growth.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected by the company's financial performance, including a 25.07% increase in H1 FY27 revenue and a 2.28% increase in PAT.
🔍
Management Signal
Management is focused on strengthening operational capabilities, maintaining financial discipline, and improving working capital efficiency to support long-term growth, as evidenced by the capacity expansion.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List - track these upcoming events
Q3 FY27 financial results — check for sustained revenue growth and margin trends.
Announcement regarding commencement of commercial production at Talod facility.
Updates on the commissioning timeline for additional manufacturing capacity.
MEDIUM RISK
Margin moderation and increased borrowings reflect potential financial pressures and investment costs.
💡 Investor Takeaway
Patel Chem Specialities reported H1 FY27 revenue from operations of ₹7,649.10 Lakhs, a 25.07% YoY increase. EBITDA grew 14.13% to ₹1,013.52 Lakhs. The company completed a second Talod facility expansion, increasing annual capacity from 720 MT to 4,500 MT, with commercial production commencing soon.
⚖️ Strengths & Concerns
✅ Positives
- Revenue from Operations increased by 25.07% YoY to ₹7,649.10 Lakhs in H1 FY27, reflecting higher reported business.
- Annual production capacity at Talod facility expanded from 720 MT to 4,500 MT, supporting market demand.
⚠️ Concerns
- PAT increased by 2.28% YoY to ₹626.90 Lakhs, while EBITDA and PAT margins moderated by 127 bps and 183 bps, respectively.
- Total long-term and short-term borrowings increased to ₹23.74 crore, from ₹15.23 crore at the end of FY26.
📅 Company Track Record
Previous filings on November 5, 2026, also reported Patel Chem Specialities' Q2 FY27 revenue at ₹7,649.10 Lakhs and profit at ₹626.90 Lakhs.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Patel Chem Specialities' revenue from operations in H1 FY27?
Patel Chem Specialities reported revenue from operations of ₹7,649.10 Lakhs for H1 FY27, marking a 25.07% increase from H1 FY26.
How much did Patel Chem Specialities' profit after tax (PAT) increase in H1 FY27?
Patel Chem Specialities' PAT increased by 2.28% to ₹626.90 Lakhs in H1 FY27, compared to ₹612.92 Lakhs in H1 FY26.
What is the new annual production capacity of Patel Chem Specialities' Talod facility?
The Talod facility's annual production capacity increased from 720 MT to 4,500 MT after its second expansion, with commercial production expected shortly.
What was the capital expenditure for Patel Chem Specialities' Talod facility expansion?
The expansion of the Talod facility involved a capital expenditure of approximately ₹20 crore, funded through bank loans and internal accruals.
What was Patel Chem Specialities' total borrowings as of September 30, 2026?
Total long-term and short-term borrowings for Patel Chem Specialities stood at ₹23.74 crore as of September 30, 2026.
Questions based on this BSE filing only. For information purposes.